Nectero Medical Recognized as a 2024 AZBio Fast Lane Award Winner
24 Sep 2024 //
GLOBENEWSWIRE
Nectero Medical Announces Completion of $96M Series D Financing
11 Apr 2024 //
BUSINESSWIRE
Nectero Announces Initiation of Phase II/III Trial of the Nectero EAST System
18 Jan 2024 //
BUSINESSWIRE
Nectero Granted Breakthrough Therapy Designation for the Nectero EAST® System
01 Nov 2023 //
BUSINESSWIRE
Nectero Medical Receives FDA Fast Track Designation for Nectero EAST® System
24 Aug 2023 //
BUSINESSWIRE